Literature DB >> 6490570

Renal tolerance and pharmacokinetics of vancomycin in rats.

R Marre, E Schulz, T Anders, K Sack.   

Abstract

The nephrotoxicity, as measured by urinary cell and enzyme excretion, of vancomycin was studied in rats. The lowest daily iv dose inducing significantly increased cell elimination was 25 mg/kg. Im administration caused less effects probably due to incomplete absorption from the im injection site, since im dosages of 100 mg/kg daily led to lower renal tissue concentrations than the same doses given iv. Nephrotoxicity of vancomycin increased when combined with tobramycin and was reduced when combined with D-glucaro-1.5-lactam, a beta-glucuronidase inhibitor. Vancomycin accumulated in renal tissue during repeated administration.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6490570     DOI: 10.1093/jac/14.3.253

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  20 in total

Review 1.  Vancomycin-induced nephrotoxicity: mechanism, incidence, risk factors and special populations. A literature review.

Authors:  Sepideh Elyasi; Hossein Khalili; Simin Dashti-Khavidaki; Amirhooshang Mohammadpour
Journal:  Eur J Clin Pharmacol       Date:  2012-03-13       Impact factor: 2.953

2.  Evaluation of Vancomycin Exposures Associated with Elevations in Novel Urinary Biomarkers of Acute Kidney Injury in Vancomycin-Treated Rats.

Authors:  Nathaniel J Rhodes; Walter C Prozialeck; Thomas P Lodise; Natarajan Venkatesan; J Nicholas O'Donnell; Gwendolyn Pais; Cameron Cluff; Peter C Lamar; Michael N Neely; Anil Gulati; Marc H Scheetz
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

3.  Intrarenal distribution of vancomycin in endotoxemic rats.

Authors:  M Ngeleka; P Auclair; D Tardif; D Beauchamp; M G Bergeron
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

4.  Pharmacokinetics of A40926 in rats after single intravenous and subcutaneous doses.

Authors:  A Bernareggi; A Danese; L Cavenaghi
Journal:  Antimicrob Agents Chemother       Date:  1988-02       Impact factor: 5.191

Review 5.  Vancomycin and the Risk of AKI: A Systematic Review and Meta-Analysis.

Authors:  Abhisekh Sinha Ray; Ammar Haikal; Kassem A Hammoud; Alan S L Yu
Journal:  Clin J Am Soc Nephrol       Date:  2016-11-28       Impact factor: 8.237

6.  Influence of fosfomycin and tobramycin on vancomycin-induced nephrotoxicity.

Authors:  R Marre; E Schulz; D Hedtke; K Sack
Journal:  Infection       Date:  1985 Jul-Aug       Impact factor: 3.553

7.  Effects of daptomycin and vancomycin on tobramycin nephrotoxicity in rats.

Authors:  D Beauchamp; M Pellerin; P Gourde; M Pettigrew; M G Bergeron
Journal:  Antimicrob Agents Chemother       Date:  1990-01       Impact factor: 5.191

Review 8.  Glycopeptides and nephrotoxicity.

Authors:  A W Chow; R M Azar
Journal:  Intensive Care Med       Date:  1994-11       Impact factor: 17.440

9.  Alanine aminopeptidase and beta 2-microglobulin excretion in patients receiving vancomycin and gentamicin.

Authors:  M J Rybak; J J Frankowski; D J Edwards; L M Albrecht
Journal:  Antimicrob Agents Chemother       Date:  1987-10       Impact factor: 5.191

10.  Subcellular localization of tobramycin and vancomycin given alone and in combination in proximal tubular cells, determined by immunogold labeling.

Authors:  D Beauchamp; P Gourde; M Simard; M G Bergeron
Journal:  Antimicrob Agents Chemother       Date:  1992-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.